The USPSTF recommends that primary care clinicians screen all adults, including pregnant women, for unhealthy alcohol use and provide brief behavioral counseling to reduce unhealthy alcohol use.
Symptoms of depression and heavy alcohol use interact to lower the chances of achieving virologic suppression in people with HIV infection.
Globally, alcohol use is a leading risk factor for disease burden.
The healthcare community, having eradicated a number of deadly diseases, should approach these alcohol-driven fatalities as a disease and launch a comprehensive, coordinated, and sustained effort to eliminate roadway deaths.
How Medication-Assisted Treatment Affects Outcomes of Alcohol-Dependent Adults With Serious Mental IllnessAugust 02, 2018
Medicine-assisted treatment demonstrated strong benefits following the treatment period, including significantly lower odds for mental health hospitalization and fewer emergency department/crisis visits.
Participants were drawn from the Health and Retirement Study, which provided multiple observations, genetic information, and previous alcohol use.
There have been substantial increases in complete abstinence from substance use reported by high school students over the past 40 years.
Technology-Enhanced Intervention in the ED Appears Promising for Reducing Underage Drinking, ConsequencesJune 28, 2018
This intervention provides flexibility in the clinical setting, allowing for therapist delivery when staff is available and computer delivery when staff resources are not available.
Binge drinking in adolescence may prevent girls from reaching their peak bone mass.
Screening adults, including pregnant women, and providing brief counseling in primary care settings can reduce unhealthy alcohol use.
Researchers emphasized the necessity of developing targeted interventions to address such health disparities among American Indian communities.
While many treatments for substance use disorder are not evidence based, several evidence-based approaches have shown effectiveness in court-mandated treatment settings.
Data support lowering limits for alcohol consumption compared with the limits in current guidelines.
Researchers proposed that future projects investigate the geographical and temporal trends in substance use and its disease burden.
A substantial proportion of these individuals diagnosed with HIV, psychiatric disorders, and substance use disorders are out of care and urgently require intervention.
Participants in the prazosin group were more likely to experience dizziness on standing.
Mortality rates decreased for alcohol use disorders, self-harm, and interpersonal violence between 1980 and 2014. Mortality rates for drug use disorders increased both nationally and in each county over the same period.
Because even moderate reductions in adolescent drinking and alcohol use disorders have the potential to reduce short- and long-term public health harms, these findings support broad implementation of the program.
Among married individuals, first alcohol use disorder registration in national medical registries is associated with an increased risk of first alcohol use disorder registration in the spouse.
Researchers calculated age-standardized mortality rates on a county level in the United States between 1980 and 2014, specifically examining rates for self-harm, interpersonal violence, alcohol use, and drug use.
These findings support the recognition of alcohol use disorders as a major risk factor for all dementia types.
Case study: new-onset amnesia occuring after cocaine and possible fentanyl use.
There has been much variability in the capacity for pharmacological treatments to help curb alcoholism, and the research community has remained interested in determining specific factors that may predict the efficacy of treatments such as naltrexone.
A multisite, cross-sectional study found a large mismatch between previously diagnosed fetal alcohol spectrum disorders and the actual prevalence of cases identified.
Not many high-risk individuals who are motivated to reduce alcohol comsumption are successful after 6 months.
The new guideline focuses on evidence-based pharmacologic treatments in alcohol use disorder and includes recommendations about naltrexone, acamprosate, disulfiram, topiramate, and gabapentin.
Alcohol use disorder and depression were both associated with higher disengagement from antiretroviral therapy for patients with HIV.
Parents should be advised that this practice is associated with risk, both directly and indirectly through increased access to alcohol from other sources.
Varenicline may have a role in the treatment of alcohol use disorder in men who smoke cigarettes.
The frequent comorbidity of bipolar disorder and alcohol use disorder presents a significant challenge for clinicians managing patients with these conditions.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Role of Expressed Emotion in Family Psychopathology
- Serum Uric Acid May Predict Bipolar Disorder in Patients With Depression
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- Health and Social Factors Predict Changes in Depressive Symptoms in Women
- ASD Risk on Offspring With Prenatal Use of Medication Affecting Neurotransmitter System
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"
- Heart Rate Variability Predicts Treatment Response in Anxious Depression
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- Efficacy, Safety of Long-Term Ketamine Administration Still In Question
- Vulnerability to Psychosocial Disability in Psychosis
- Behavioral Health Screening Advocated for Teens With Epilepsy
- KCNQ Channel Potentiator Ezogabine Delivers Promising Results in Major Depressive Disorder
- Increase Seen in Amphetamine, Opioid Use in Pregnant Women